Other OTC - Delayed Quote USD

Evofem Biosciences, Inc. (EVFM)

0.0168 +0.0026 (+17.96%)
At close: 3:58 PM EDT
Key Events
Loading Chart for EVFM
DELL
  • Previous Close 0.0142
  • Open 0.0130
  • Bid --
  • Ask --
  • Day's Range 0.0130 - 0.0185
  • 52 Week Range 0.0120 - 3.7500
  • Volume 555,899
  • Avg. Volume 839,233
  • Market Cap (intraday) 769,486
  • Beta (5Y Monthly) -1.16
  • PE Ratio (TTM) 0.34
  • EPS (TTM) 0.0500
  • Earnings Date May 30, 2024 - Jun 3, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

www.evofem.com

37

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EVFM

Performance Overview: EVFM

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EVFM
73.83%
S&P 500
6.92%

1-Year Return

EVFM
99.36%
S&P 500
25.26%

3-Year Return

EVFM
100.00%
S&P 500
22.00%

5-Year Return

EVFM
100.00%
S&P 500
74.29%

Compare To: EVFM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVFM

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    652.34k

  • Enterprise Value

    44.03M

  • Trailing P/E

    0.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.77

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.42

  • Enterprise Value/EBITDA

    -2.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    290.81%

  • Return on Assets (ttm)

    -62.46%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    18.22M

  • Net Income Avi to Common (ttm)

    49.99M

  • Diluted EPS (ttm)

    0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -7.15M

Research Analysis: EVFM

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: EVFM

Fair Value

0.0168 Current
 

Dividend Score

0 Low
EVFM
Sector Avg.
100 High
 

Hiring Score

0 Low
EVFM
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
EVFM
Sector Avg.
100 High
 

Research Reports: EVFM

  • Daily – Vickers Top Insider Picks for 09/09/2021

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 09/08/2021

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 09/03/2021

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 09/02/2021

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

People Also Watch